Embryonic Stem Cells News and Research

RSS

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

Ever since researchers devised a recipe for turning adult cells into cells that look and act like embryonic stem cells, there has been lingering doubt in the field about just how close to embryonic stem cells each of those cell lines really is at a molecular and functional level. Now, researchers reporting in the February 4th issue of the journal Cell, a Cell Press publication, have developed a systematic way to lay those doubts about quality to rest.

4 Feb 2011

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.

4 Feb 2011

Researchers find better way to create iPS cells from blood samples

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

2 Feb 2011

Scientists devise safer way to create iPS cells

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

1 Feb 2011

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.

14 Jan 2011

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Scientists have developed Australia's first adult induced pluripotent stem cell lines using skin biopsies from patients with the rare genetic disease Friedreich Ataxia.

14 Jan 2011

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

13 Jan 2011

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers at Nationwide Children's Hospital report a gene therapy strategy that improves the condition of a mouse model of an inherited blood disorder, Beta Thalassemia.

11 Jan 2011

ddn conducts interview with lead plaintiff related to embryonic stem cell research case

Drug Discovery News, a news organization covering issues, trends and product news in the pharmaceutical drug development and discovery industry, recently conducted exclusive interviews with the lead plaintiffs in the controversial Sherley v. Sebelius lawsuit challenging President Barack Obama's order granting funding for embryonic stem cell research.

4 Jan 2011

CDK1 protein deactivates EZH2 enzyme that causes cancer spread

By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology.

4 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

ISCO to conduct discussion on ethical and medical advantages of human parthenogenetic stem cells

International Stem Cell Corporation, will lead a free public discussion highlighting the ethical considerations and medical advantages surrounding the derivation of human stem cells from unfertilized human eggs using ISCO's patented technology known as parthenogenesis.

29 Dec 2010

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Advanced Cell Technology, a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future.

28 Dec 2010

The Hill: GOP leaders for House Energy and Commerce health panel named

Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.

20 Dec 2010

Whitehead Institute Founding Member named recipient of 2011 Warren Triennial Prize of MGH

Whitehead Institute Founding Member Rudolf Jaenisch has been named a recipient of the 2011 Warren Triennial Prize of Massachusetts General Hospital.

17 Dec 2010

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

In a paper published in the journal PLoS One, the researchers demonstrated that culturing mouse embryonic stem cells on a soft gel rather than on a hard plate or dish keeps them in their pluripotent state, a ground state with the ability to become any type of tissue.

16 Dec 2010

Embryonic Stem Cells News and Research

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

Researchers find better way to create iPS cells from blood samples

Scientists devise safer way to create iPS cells

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

ddn conducts interview with lead plaintiff related to embryonic stem cell research case

CDK1 protein deactivates EZH2 enzyme that causes cancer spread

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

ISCO to conduct discussion on ethical and medical advantages of human parthenogenetic stem cells

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

The Hill: GOP leaders for House Energy and Commerce health panel named

Whitehead Institute Founding Member named recipient of 2011 Warren Triennial Prize of MGH

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

Novel labeling technique helps researchers to explore DNA chemical modification

Scientists create functioning human intestinal tissue from pluripotent stem cells

Stem cell biology offers great hope for eventual repair of body parts

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News